Molecular Testing in Pancreatic Cancer

M. J. Bartel, S. Chakraborty, M. Raimondo

Research output: Chapter in Book/Report/Conference proceedingChapter


Pancreatic cancer is a relatively rare, but lethal disease with one of the lowest survival rates after diagnosis. Pancreatic cancer is usually diagnosed late during the course of the disease which accounts for its high mortality rate. To diagnose pancreatic cancer at early stage is challenging because this cancer may not be responsible for symptoms and patients may not look for medical attention until the cancer has already spread locally or to distant organs. Consequently, we are constantly looking for molecular markers that can identify early pancreatic cancer and hopefully offer treatments that can confidently impact survival in individual patients after diagnosis. This chapter summarizes the available evidence regarding molecular markers developed to improve the early diagnosis of pancreatic cancer using human specimens including serum, pancreatic juice, bile, stool, urine, and tissue.

Original languageEnglish (US)
Title of host publicationDiagnostic Molecular Pathology
Subtitle of host publicationA Guide to Applied Molecular Testing
Number of pages11
ISBN (Electronic)9780128008867
ISBN (Print)9780128011577
StatePublished - Jan 1 2016


  • bile
  • biomarker
  • molecular testing
  • Pancreatic cancer
  • pancreatic juice
  • saliva
  • serum

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Molecular Testing in Pancreatic Cancer'. Together they form a unique fingerprint.

Cite this